华熙生物(688363.SH)：国寿成达拟减持不超2%股份

Core Viewpoint - Guoshou Chengda plans to reduce its holdings in Huaxi Biological by up to 9.6336 million shares, representing no more than 2% of the company's total share capital [1] Summary by Category - Share Reduction Plan - Guoshou Chengda intends to reduce its stake in Huaxi Biological through centralized bidding and block trading methods [1] - The total number of shares to be reduced is up to 9.6336 million [1] - The proposed reduction accounts for a maximum of 2% of the company's total share capital [1]